177PDProspective, multicenter registry trial to evaluate the clinical feasibility of targeted axillary dissection (TAD) in patients (pts) with breast cancer (BC) and core biopsy proven axillary involvement (cN+)
Reinisch, M, Heil, J, Rüland, A, Seiberling, C, Harrach, H, Schindowski, D, Lubitz, J, Ankel, C, Graßhoff, S -T, Deuschle, P, Hanf, V, Holtschmidt, J, Traut, E, Kuehn, T, Kuemmel, SVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz240.003
Date:
October, 2019
File:
PDF, 79 KB
english, 2019